Ivermectin
| dc.contributor.author | Heimfarth, Luana | |
| dc.contributor.author | Santos, Victor Santana | |
| dc.contributor.author | Araújo, Adriano Antunes de Souza | |
| dc.contributor.author | Quintans-Júnior, Lucindo José | |
| dc.contributor.author | Martins-Filho, Paulo Ricardo | |
| dc.date.accessioned | 2020-12-18T11:23:11Z | |
| dc.date.available | 2020-12-18T11:23:11Z | |
| dc.date.issued | 2020-11-09 | |
| dc.identifier.citation | Heimfarth, L., Santos, V. S. ., Araújo, A. A. de S. ., Quintans-Júnior, L. J. ., & Martins-Filho, P. R. . (2020). Ivermectin: Panacea or true promise for COVID-19. EXCLI Journal, 19, 1517-1519. https://doi.org/10.17179/excli2020-3022 | en |
| dc.identifier.issn | 1611-2156 | |
| dc.identifier.uri | http://hdl.handle.net/2003/39937 | |
| dc.identifier.uri | http://dx.doi.org/10.17877/DE290R-21827 | |
| dc.language.iso | en | |
| dc.publisher | IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund | en |
| dc.relation.ispartofseries | EXCLI Journal;Vol. 19 2020 | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | SARS-CoV-2 | en |
| dc.subject | Ivermectin | en |
| dc.subject | Drug | en |
| dc.subject.ddc | 610 | |
| dc.title | Ivermectin | en |
| dc.title.alternative | Panacea or true promise for COVID-19 | en |
| dc.type | Text | |
| dc.type.publicationtype | article | |
| dcterms.accessRights | open access | |
| eldorado.dnb.deposit | true | de |
| eldorado.dnb.zdberstkatid | 2132560-1 | |
| eldorado.identifier.url | https://www.excli.de/index.php/excli/article/view/3022 | |
| eldorado.secondarypublication | true |
